Angiogenic and hypoxia markers in non-small cell lung cancers: evaluation of clinical and prognostic
Angiogenic markers show high prognostic impact on survival in marginally operable non-small cell lung cancer patients treated with adjuvant radiotherapy.
J Thorac Oncol 2009 Apr;4(4):463-71.
Prognostic impact of platelet-derived growth factors in non-small cell lung cancer tumor and stromal cells.
J Thorac Oncol 2008 Sep;3(9):963-70.
Diverging prognostic impacts of hypoxic markers in histologic non-small cell lung cancer (NSCLC) subtypes
13th world conference on lung cancer, San Fransisco, CA, USA. Journal of thoracic oncology. Abstract D3.4; 4(9): S5-S968, September 2009. doi:10.1097
Immunohistochemical Expression of ErbB Family Receptors in Non-Small Cell Lung Cancer (NSCLC)
Oral presentation. BIT's 2nd Annual Congress and Expo of Molecular Diagnostics (CEMD-2009). Beijing, China, November 2009
Angiogenic markers show high prognostic impact on survival in marginally operable non-small cell lung cancer patients treated wi
"In press" i Journal of Thoracic Oncology